论文部分内容阅读
目的:为准确及时对恶性肿瘤患者的输血安全治疗。方法:对本院400例输血患者的标本进行聚凝胺交叉配血试验,其中试验组临床诊断恶性肿瘤患者200例,对照组临床诊断非肿瘤患者200例。结果:2组输血患者的标本对聚凝胺交叉配血试验的干扰差异有统计学意义(P<0.01)。结论:恶性肿瘤患者的输血标本对聚凝胺交叉配血试验存在干扰因素,应及时进行处理,以确保患者输血安全治疗。
Objective: To accurately and timely transfusion safety treatment for patients with malignant tumors. Methods: Polybrene crossmatch test was performed on 400 transfused patients in our hospital. Among them, 200 cases of malignant tumors were clinically diagnosed in the experimental group and 200 cases of non-tumor were diagnosed in the control group. Results: There were significant differences in the interference between the two groups of blood transfusion patients in the crossover blood test of polybrene (P <0.01). CONCLUSION: The transfusion samples of patients with malignant tumor have interference factors on the cross-matching test of polybrene and should be treated promptly to ensure the safe transfusion of blood transfusion.